Clinical Trial Update: Venetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating venetoclax in combination with ibrutinib for chronic lymphocytic leukemia and small lymphocytic lymphoma, including rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• IMBRUVICA (IBRUTINIB)
• Venclexta (venetoclax)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING